VRAX Competitors & Alternatives
Compare Virax Biolabs Group Limited Ordinary Shares with similar stocks in the same industry
In Vitro & In Vivo Diagnostic Substances
VRAX
Main Stock$0.27
Tradestie Score
50
Market Cap
$2.69M
Revenue Growth
-0.7%
Analyst Upside
+1002.9%
Top Competitors
19 stocks in In Vitro & In Vivo Diagnostic Substances| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
IDXX
Idexx Laboratories Inc
|
$639.60
|
$49.61B | 53.8 | 40 | Compare |
|
LNTH
Lantheus Holdings, Inc
|
$66.50
|
$3.51B | 27.7 | 57 | Compare |
|
QDEL
QuidelOrtho Corporation Common Stock
|
$27.65
|
$2.12B | - | 54 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$13.06
|
$2.01B | - | 57 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$24.66
|
$1.68B | - | 48 | Compare |
|
NNNN
Anbio Biotechnology Class A Ordinary Shares
|
$24.66
|
$1.53B | 365.2 | 41 | Compare |
|
NEOG
Neogen Corp
|
$10.25
|
$1.26B | - | 59 | Compare |
|
MYGN
Myriad Genetics Inc
|
$5.47
|
$719.23M | - | 49 | Compare |
|
TKNO
Alpha Teknova, Inc. Common Stock
|
$2.37
|
$340.89M | - | 50 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$4.30
|
$158.43M | - | 41 | Compare |
More VRAX Analysis
Data updated: Feb 03, 2026 | Industry: In Vitro & In Vivo Diagnostic Substances (SIC 2835)
19 stocks in this industry